Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:prph | https://www.glassdoor.com?employer_id=7444 | 7444 | Apr 28th, 2024 12:00AM | Open | ProPhase Labs | Open | Company - Public | Biotech & Pharmaceuticals | Doylestown, PA | 3.10 | 67% | 45% | 42% | 4.10 | 3.60 | 3.20 | 3.50 | 3.50 | 3.30 | 1.00 | 2.00 | 1.00 | 3.00 | 7.00 | 6.00 | 7.00 | 14.286% | 28.571% | 14.286% | 42.857% | 0.00 | 0.00 | 13.00 | 1.00 | Ted Karkus | Apr 28th, 2024 04:22PM | Apr 28th, 2024 04:22PM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||||||||||||||||||
nasdaq:prph | https://www.glassdoor.com?employer_id=7444 | 7444 | Apr 26th, 2024 12:00AM | Open | ProPhase Labs | Open | Company - Public | Biotech & Pharmaceuticals | Doylestown, PA | 3.10 | 67% | 45% | 42% | 4.10 | 3.60 | 3.20 | 3.50 | 3.50 | 3.30 | 1.00 | 2.00 | 1.00 | 3.00 | 7.00 | 6.00 | 7.00 | 14.286% | 28.571% | 14.286% | 42.857% | 0.00 | 0.00 | 13.00 | 1.00 | Ted Karkus | Apr 26th, 2024 08:08AM | Apr 26th, 2024 08:08AM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||||||||||||||||||
nasdaq:prph | https://www.glassdoor.com?employer_id=7444 | 7444 | Apr 25th, 2024 12:00AM | Open | ProPhase Labs | Open | Company - Public | Biotech & Pharmaceuticals | Doylestown, PA | 3.10 | 67% | 45% | 42% | 4.10 | 3.60 | 3.20 | 3.50 | 3.50 | 3.30 | 1.00 | 2.00 | 1.00 | 3.00 | 7.00 | 6.00 | 7.00 | 14.286% | 28.571% | 14.286% | 42.857% | 0.00 | 0.00 | 13.00 | 1.00 | Ted Karkus | Apr 25th, 2024 06:30PM | Apr 25th, 2024 06:30PM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||||||||||||||||||
nasdaq:prph | https://www.glassdoor.com?employer_id=7444 | 7444 | Apr 24th, 2024 12:00AM | Open | ProPhase Labs | Open | Company - Public | Biotech & Pharmaceuticals | Doylestown, PA | 3.10 | 67% | 45% | 42% | 4.10 | 3.60 | 3.20 | 3.50 | 3.50 | 3.30 | 1.00 | 2.00 | 1.00 | 3.00 | 1.00 | 8.00 | 6.00 | 7.00 | 12.5% | 25% | 12.5% | 37.5% | 12.5% | 0.00 | 0.00 | 13.00 | 1.00 | Ted Karkus | Apr 24th, 2024 10:53AM | Apr 24th, 2024 10:53AM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||||||||||||||||
nasdaq:prph | https://www.glassdoor.com?employer_id=7444 | 7444 | Apr 23rd, 2024 12:00AM | Open | ProPhase Labs | Open | Company - Public | Biotech & Pharmaceuticals | Doylestown, PA | 3.10 | 67% | 45% | 42% | 4.10 | 3.60 | 3.20 | 3.50 | 3.50 | 3.30 | 1.00 | 2.00 | 1.00 | 3.00 | 1.00 | 8.00 | 6.00 | 7.00 | 12.5% | 25% | 12.5% | 37.5% | 12.5% | 0.00 | 0.00 | 13.00 | 1.00 | Ted Karkus | Apr 23rd, 2024 04:27PM | Apr 23rd, 2024 04:27PM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||||||||||||||||
nasdaq:prph | https://www.glassdoor.com?employer_id=7444 | 7444 | Apr 21st, 2024 12:00AM | Open | ProPhase Labs | Open | Company - Public | Biotech & Pharmaceuticals | Doylestown, PA | 3.10 | 67% | 45% | 42% | 4.10 | 3.60 | 3.20 | 3.50 | 3.50 | 3.30 | 1.00 | 2.00 | 1.00 | 3.00 | 1.00 | 8.00 | 6.00 | 7.00 | 12.5% | 25% | 12.5% | 37.5% | 12.5% | 0.00 | 0.00 | 13.00 | 1.00 | Ted Karkus | Apr 21st, 2024 04:28PM | Apr 21st, 2024 04:28PM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||||||||||||||||
nasdaq:prph | https://www.glassdoor.com?employer_id=7444 | 7444 | Apr 20th, 2024 12:00AM | Open | ProPhase Labs | Open | Company - Public | Biotech & Pharmaceuticals | Doylestown, PA | 3.10 | 67% | 45% | 42% | 4.10 | 3.60 | 3.20 | 3.50 | 3.50 | 3.30 | 1.00 | 2.00 | 1.00 | 3.00 | 1.00 | 8.00 | 6.00 | 7.00 | 12.5% | 25% | 12.5% | 37.5% | 12.5% | 0.00 | 0.00 | 13.00 | 1.00 | Ted Karkus | Apr 20th, 2024 04:44PM | Apr 20th, 2024 04:44PM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||||||||||||||||
nasdaq:prph | https://www.glassdoor.com?employer_id=7444 | 7444 | Apr 19th, 2024 12:00AM | Open | ProPhase Labs | Open | Company - Public | Biotech & Pharmaceuticals | Doylestown, PA | 3.10 | 67% | 45% | 42% | 4.10 | 3.60 | 3.20 | 3.50 | 3.50 | 3.30 | 1.00 | 2.00 | 1.00 | 3.00 | 1.00 | 8.00 | 6.00 | 7.00 | 12.5% | 25% | 12.5% | 37.5% | 12.5% | 0.00 | 0.00 | 13.00 | 1.00 | Ted Karkus | Apr 19th, 2024 07:41AM | Apr 19th, 2024 07:41AM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||||||||||||||||
nasdaq:prph | https://www.glassdoor.com?employer_id=7444 | 7444 | Apr 18th, 2024 12:00AM | Open | ProPhase Labs | Open | Company - Public | Biotech & Pharmaceuticals | Doylestown, PA | 3.10 | 67% | 45% | 42% | 4.10 | 3.60 | 3.20 | 3.50 | 3.50 | 3.30 | 1.00 | 2.00 | 1.00 | 3.00 | 1.00 | 8.00 | 6.00 | 7.00 | 12.5% | 25% | 12.5% | 37.5% | 12.5% | 0.00 | 0.00 | 13.00 | 1.00 | Ted Karkus | Apr 18th, 2024 06:03PM | Apr 18th, 2024 06:03PM | ProPhase Labs | Pharmaceuticals & Biotechnology | ||||||||||||||||
nasdaq:prph | https://www.glassdoor.com?employer_id=7444 | 7444 | Apr 17th, 2024 12:00AM | Open | ProPhase Labs | Open | Company - Public | Biotech & Pharmaceuticals | Doylestown, PA | 3.10 | 67% | 45% | 42% | 4.10 | 3.60 | 3.20 | 3.50 | 3.50 | 3.30 | 1.00 | 2.00 | 1.00 | 3.00 | 1.00 | 8.00 | 6.00 | 7.00 | 12.5% | 25% | 12.5% | 37.5% | 12.5% | 0.00 | 0.00 | 13.00 | 1.00 | Ted Karkus | Apr 17th, 2024 02:30PM | Apr 17th, 2024 02:30PM | ProPhase Labs | Pharmaceuticals & Biotechnology |